Global Assisted Reproductive Technology Market Size, Growth: By Procedure: Fresh Donor, Fresh Nondonor, Frozen Donor, Frozen Nondonor, Embryo/Egg Banking; By Age: Women Younger Than Age 35, Women Older Than Age 35; By Application; By End User; Regional Analysis; Patent Analysis; Grants Analysis; Supplier Landscape; 2024-2032

Global Assisted Reproductive Technology Market Outlook

The global assisted reproductive technology market size was valued at USD 15.14 billion in 2023, driven by the increasing infertility issues across the globe. The market size is anticipated to grow at a CAGR of 4.4% during the forecast period of 2024-2032 to achieve a value of USD 22.30 billion by 2032.

Global Assisted Reproductive Technology Market Overview

The increasing advancements in the field by key players are expected to drive the growth of the market in the coming years. The expanding applications of AI in assisted reproductive technology (ART) are expected to further propel the market demand. Advanced technologies, such as precision 3D printing and advanced microscopes, are expected to assist in identifying embryos and promoting healthy pregnancy, further propelling the global assisted reproduction technology market demand.

The rapidly advancing technology is enabling people to conceive even when they are having medical issues. Such advanced technologies are directly contributing to the increasing demand, further fuelling the market growth. A few examples of assisted reproductive technologies include In-vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), Gamete Intrafallopian Transfer (GIFT), and Zygote Intrafallopian Transfer (ZIFT), among others.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

A significant rise in the adoption of these advancing technologies for broader adoption with increasing awareness among healthcare professionals is expected to propel the market growth. The rising cases of infertility worldwide are leading to the increased adoption of assisted reproduction technology (ART), contributing significantly to the assisted reproductive technology market share. The high success rates of ART across the globe are gaining traction while providing hope to people who have some medical issues but look forward to conceiving in the coming future. The increasing disposable income among people mostly in developing countries is also contributing to the market growth.

Rising Prevalence of Infertility

The growth of the market is primarily driven by the rising prevalence of infertility and other reproductive issues across the world. Infertility affects  millions of people every year, one in every six people of reproductive age, which is nearly 17.5% of the total adult population, is affected by infertility in their life. Assisted reproductive technologies have been in the market for over three decades and have intervened in the birth of more than 5 million children across the world. These technologies are still widely inaccessible because of the price point, which is unaffordable for majority of the population, especially in low-income countries.

Technological Advancements Bolstering the Assisted Reproductive Technology Market Growth

The key players in the market are focusing on developing advanced healthcare systems to assist people in need of assisted reproduction technology, which is further expected to greatly influence the assisted reproduction technology market demand. Technologies like machine learning models are being introduced in the market to optimise hormonal treatments, including FSH (follicle-stimulating hormone) for better results. Other than that, various innovative platforms have been working on enabling remote monitoring and testing, various efforts are being made in electronic witnessing systems and robotic cryopreservation systems, which can help streamline the whole system of tracking and preserving eggs, sperms, and embryos. AI tools are one of the biggest developments in the healthcare sector, these tools are widely being used to enhance the fertility outcomes and make it more cost-effective. For instance, in October 2022, Alife, after doing thorough research and development for over two years, introduced a new AI based software that can aid fertility clinics to improve fertility outcomes by optimising and supporting the critical decisions during the process of IVF.

Global Recognition by Regulatory Authorities to Act as a Key Driver for the Assisted Reproductive Technology Market Growth

In April 2023, TMRW Life Sciences, a fertility technology company automating the IVF lab, announced  receiving a CE Mark for the CryoRobot Select (CRS). The European designation follows clearance by the U.S. Food and Drug Administration, and the two regulatory achievements demonstrate that TMRW's automated platform for the safe management and storage of frozen eggs and embryos is now the global standard. TMRW’s recognition as a global standard is expected to increase the widespread adaptation of this technology to make the whole process safer and more standardized.

Strategic Acquisition Activities by Key Players

The rising competition amongst the key players is also aiding the assisted reproductive technology market growth. In July 2023, Baring Private Equity Asia (BPEA) EQT agreed to acquire a controlling stake in Indira IVF from TA Associates and the company’s founders. BPEA EQT is expected to acquire a 60% stake for USD 656.6 million. As India is one of the fastest-growing markets globally for assisted reproductive technology services, this acquisition is further anticipated to increase the market reach in more developed markets with this acquisition, driving the market growth.

Rising Support from the Government to Support the Growth of the Assisted Reproductive Technology Market

The growth of the market is driven by the increasing initiatives by governments towards the regulation of practices as safe and effective for the people acquiring assistance from such services. For instance, In April 2023, the Ministry of Health and Family Welfare (MoHFW) rolled back the manner of retrieving oocytes and placing embryos vide assisted reproductive technology regulations in a manner where the health of the patient would not be compromised.

Additionally, In June 2023, the government of Beijing announced that they will cover 16 types of assisted reproduction technology under the city's health care system. This is an effort to boost China's declining birth rate. In-vitro fertilisation, embryo transplantation, freezing, and storing semen are some of the treatments that will be included under basic insurance. This initiative by the government is expected to drive the market growth by encouraging people to have babies.  The expenses of these services will be covered under health insurance, making it more convenient for people to avail of the services. This change is expected to increase the adaptation and demand for these services in the market during the forecast period. It could potentially lead to more people using these methods to have babies, which in turn could increase the number of births in Beijing.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Assisted Reproductive Technology Market Segmentations

Market Breakup by Procedure

• Fresh Donor

• Fresh Nondonor

• Frozen Donor

• Frozen Nondonor

• Embryo/Egg Banking

Market Breakup by Age

• Women Younger than age 35

• Women Older than age 35

Market Breakup by Application

• Artificial Insemination - Intrauterine Insemination (AI-IUI)

• Frozen Embryo Replacement (FER)

• Surrogacy

• Ovulation Induction

• Others

Market Breakup by End User

• Hospitals

• Fertility Clinics

• Others

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Assisted Reproductive Technology Market Regional Analysis

North America has been leading the global market for assisted reproductive technology and it is likely to continue dominating the market in the forecast period. The region is anticipated to dominate in the forecast period due to the robust healthcare infrastructure and decreasing fertility, increasing research activities. The region is likely to continue dominating the global market owing to the presence of renowned clinics in the region.

In October 2023, Hamilton Thorne Ltd., a leading provider of precision instruments, consumables, software, and services to the Assisted Reproductive Technologies ("ART") research and cell biology markets, announced that they have acquired Gynetics Medical Products, N.V. and Gynetics Services B.V. (collectively, "Gynetics"). Gynetics, based in Lommel, Belgium is a leading manufacturer of a wide range of innovative, high-quality In Vitro Fertilization ("IVF") devices in the global IVF market. The acquisition is poised to highlight Hamilton Thorne's consumables product offerings and increase the market reach for profitable operations in the well-established European ART market.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Assisted Reproductive Technology Market: Competitor Landscape

In June 2023, FUJIFILM Irvine Scientific, Inc., a global leader in the innovation and manufacture of cell culture solutions for the Life Science and Medical markets, announced the addition of the Life Whisperer Genetics module to its Life Whisperer software package, enabling non-invasive evaluation of embryo genetic integrity during in vitro fertilization (IVF). Life Whisperer Genetics, when combined with Life Whisperer Viability, offers a distinctive way to help choose blastocysts during clinical processes. This combined platform helps identify blastocysts with a higher chance of being euploid and leading to successful pregnancies, all within a single system.

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.

The major companies in the assisted reproductive technology market are as follows:

• California Cryobank

• Bloom Fertility Centre

• Anecova

• CooperSurgical

• Merck KGaA

• Ferring B.V.

• FUJIFILM Irvine Scientific

• Genea Limited

• Nidacon International AB

• Celmatix Inc.

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.